William Nassib William

1.4k total citations
44 papers, 810 citations indexed

About

William Nassib William is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, William Nassib William has authored 44 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in William Nassib William's work include Lung Cancer Treatments and Mutations (16 papers), Head and Neck Cancer Studies (10 papers) and Lung Cancer Research Studies (9 papers). William Nassib William is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Head and Neck Cancer Studies (10 papers) and Lung Cancer Research Studies (9 papers). William Nassib William collaborates with scholars based in United States, Brazil and France. William Nassib William's co-authors include Bonnie S. Glisson, Rui Curi, Rolando B. Ceddia, J. Jack Lee, Vassiliki A. Papadimitrakopoulou, Elie Mouhayar, Cezar Iliescu, Syed Wamique Yusuf, Juhee Song and John V. Heymach and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Cancer.

In The Last Decade

William Nassib William

41 papers receiving 793 citations

Peers

Countries citing papers authored by William Nassib William

Since Specialization

Citations

This map shows the geographic impact of William Nassib William's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Nassib William with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Nassib William more than expected).

Fields of papers citing papers by William Nassib William

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Nassib William. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Nassib William. The network helps show where William Nassib William may publish in the future.

Co-authorship network of co-authors of William Nassib William

This figure shows the co-authorship network connecting the top 25 collaborators of William Nassib William. A scholar is included among the top collaborators of William Nassib William based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Nassib William. William Nassib William is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted Therapy for the Management of Oral Potentially Malignant Disorders: A Systematic Review 2025 ·Oral Diseases ·Lauren Frenzel Schuch, Fábio Muradás Girardi, (unknown), Aline Lauda Freitas Chaves, Luiz Paulo Kowalski, Ronell Bologna‐Molina, William Nassib William, Manoela Domingues Martins, Alan Roger Santos‐Silva	0
2	Tisotumab vedotin in head and neck squamous cell carcinoma: Updated analysis from innovaTV 207 Part C. 2024 ·Journal of Clinical Oncology ·Lova Sun, Jérôme Fayette, Sébastien Salas, David S. Hong, Douglas R. Adkins, Lara Dunn, Fortunato Ciardiello, Beatriz Cirauqui, William Nassib William, Nabil F. Saba, Christine H. Chung, Ariel E. Birnbaum, Dan P. Zandberg, Allison Wehr, Leonardo Nicacio, Ibrahima Soumaoro, Anne‐Sophie Carret, Tanguy Y. Seiwert	7
3	The impact of colonialism on head and neck cancer in Brazil: a historical essay focussing on tobacco, alcohol and slavery 2024 ·The Lancet Regional Health - Americas ·(unknown), (unknown), Felipe Paiva Fonseca, William Nassib William, Thiago Bueno de Oliveira, Gustavo Nader Marta, Aline Lauda Freitas Chaves, Ana Carolina Prado Ribeiro, Olalekan Ayo‐Yusuf, María Paula Curado, (unknown), Luiz Paulo Kowalski, Alan Roger Santos‐Silva, (unknown), (unknown), (unknown)	4
4	SUNRAY-01, a pivotal, global study of olomorasib (LY3537982) in combination with pembrolizumab with or without chemotherapy for 1L treatment in KRAS G12C-mutant advanced NSCLC. 2024 ·Journal of Clinical Oncology ·Marcelo V. Negrão, Kathryn C. Arbour, Timothy F. Burns, Federico Cappuzzo, Anne‐Marie C. Dingemans, Nicolas Girard, Bjørn Henning Grønberg, Maximilian J. Hochmair, Ticiana Leal, Colin R. Lindsay, Shun Lu, (unknown), Luis Paz‐Ares, Martin Reck, Joshua K. Sabari, Alexander I. Spira, William Nassib William, Aaron Chen, (unknown), Solange Peters	3
5	Selpercatinib and capmatinib combination promotes sustained complete response in novel ISOC1-RET fusion lung cancer after resistance to RET inhibitor via MET amplification: Case Report 2023 ·Frontiers in Oncology ·Caio A. Leite, (unknown), (unknown), (unknown), (unknown), William Nassib William	5
6	A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial. 2023 ·Journal of Clinical Oncology ·Thiago Bueno de Oliveira, (unknown), T. Motta, Andrea Juliana Gomes, Iane Pinto Figueiredo Lima, (unknown), Luiz H. Araujo, Milena Perez Mak, Kathia Cristina Abdalla, Gustavo Nader Marta, Marcos Santos, (unknown), Gustavo Werutsky, (unknown), William Nassib William	0
7	Open-label, randomized, multicenter, phase 3 study evaluating trastuzumab deruxtecan (T-DXd) as first-line treatment in patients with unresectable, locally advanced, or metastatic non–small cell lung cancer (NSCLC) harboring HER2 exon 19 or 20 mutations (DESTINY-Lung04). 2022 ·Journal of Clinical Oncology ·Bob T. Li, Myung‐Ju Ahn, Kōichi Goto, (unknown), Sukhmani K. Padda, William Nassib William, Yi‐Long Wu, Simon Dearden, Alejandra Ragone, (unknown), Amaya Gascó	9
8	innovaTV 207: New combination dosing cohorts in the open label phase 2 study of tisotumab vedotin in solid tumors. 2022 ·Journal of Clinical Oncology ·Xiuning Le, Benedito A. Carneiro, David S. Hong, Ariel E. Birnbaum, Matthew H. Taylor, Shetal Patel, William Nassib William, Bokai Wang, (unknown), Shweta Jain, Ibrahima Soumaoro, Lara Dunn	5
9	A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma 2021 ·Radiotherapy and Oncology ·Eddy S. Yang, Éric Deutsch, Mehmet Altan, Jérôme Fayette, Yungan Tao, Lisle Nabell, Sharon A. Spencer, (unknown), (unknown), Wei Zhang, Scott M. Hynes, (unknown), (unknown), William Nassib William	19
10	Oral leukoplakia and erythroplakia in young patients: a systematic review 2020 ·Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ·Ana Luiza Oliveira Corrêa Roza, Luiz Paulo Kowalski, William Nassib William, Gilberto de Castro, Aline Lauda Freitas Chaves, Anna Luíza Damaceno Araújo, Ana Carolina Prado Ribeiro, Thaís Bianca Brandão, Márcio Ajudarte Lopes, Pablo Agustín Vargas, Alan Roger Santos‐Silva	12
11	Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: A systematic review and meta-analysis 2020 ·Critical Reviews in Oncology/Hematology ·Bruno Augusto Linhares Almeida Mariz, Luiz Paulo Kowalski, William Nassib William, Gilberto de Castro, Aline Lauda Freitas Chaves, (unknown), Thiago Bueno de Oliveira, Anna Luíza Damaceno Araújo, Ana Gabriela Costa Normando, Ana Carolina Prado Ribeiro, Thaís Bianca Brandão, Pablo Agustín Vargas, Márcio Ajudarte Lopes, Alan Roger Santos‐Silva	38
12	Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC): Clinical and correlative results from the NEOSTAR study. 2019 ·Journal of Clinical Oncology ·Tina Cascone, William Nassib William, Annikka Weissferdt, Heather Lin, Cheuk Hong Leung, Brett W. Carter, Frank V. Fossella, Frank E. Mott, Vassiliki A. Papadimitrakopoulou, George R. Blumenschein, Xiuning Le, Lorenzo Federico, Edwin R. Parra, Chantale Bernatchez, Ignacio I. Wistuba, Ara A. Vaporciyan, Don L. Gibbons, Stephen G. Swisher, John V. Heymach, Boris Sepesi, (unknown)	108
13	Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion 2015 ·Journal of the American College of Cardiology ·(unknown), Cezar Iliescu, Syed Wamique Yusuf, William Nassib William, (unknown), Juhee Song, Elie Mouhayar	76
14	Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome 2015 ·American Journal of Ophthalmology ·(unknown), Vivian T. Yin, (unknown), (unknown), Merrill S. Kies, William Nassib William, Michael R. Migden, Bradley A. Thuro, Bita Esmaeli	46
15	Novel strategies for the treatment of small-cell lung carcinoma 2011 ·Nature Reviews Clinical Oncology ·William Nassib William, Bonnie S. Glisson	82
16	High-dose interleukin-2 in patients with metastatic melanoma whose disease progressed after biochemotherapy 2011 ·Melanoma Research ·Antônio C. Buzaid, (unknown), (unknown), Daniela Freitas, William Nassib William	2
17	Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall‐cell lung cancer 2010 ·Cancer ·William Nassib William, Merrill S. Kies, Frank V. Fossella, Diane D. Liu, Gregory W. Gladish, (unknown), J. Jack Lee, Waun Ki Hong, Scott M. Lippman, Edward S. Kim	14
18	Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma 2010 ·Cancer ·William Nassib William, (unknown), Faye M. Johnson, Lei Feng, (unknown), Frank V. Fossella, Daniel D. Karp, George R. Blumenschein, David J. Stewart, Bonnie S. Glisson	1
19	Leptin stimulates uncoupling protein‐2 mRNA expression and Krebs cycle activity and inhibits lipid synthesis in isolated rat white adipocytes 2000 ·European Journal of Biochemistry ·Rolando B. Ceddia, William Nassib William, Fábio Bessa Lima, (unknown), Rui Curi, Jean‐Paul Giacobino	58
20	Leptin Increases Glucose Transport and Utilization in Skeletal Muscle in Vitro 1998 ·General Pharmacology The Vascular System ·Rolando B. Ceddia, William Nassib William, Rui Curi	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact